Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase NA 7Phase 3 6Phase EARLY_PHASE1 1Phase 2/3 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 20Gastrointestinal 13Sarcoma 9Thoracic 6Head & Neck 6Breast 4Other solid neoplasm 2Gynecologic 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Neoplasm Metastasis 1Melanoma 1

Interventions

pembrolizumab 100Nivolumab 69Cyclophosphamide 67Ipilimumab 66fludarabine 34aldesleukin 29fludarabine phosphate 28Vemurafenib 28Interleukin-2 26trametinib 20Biopsy 20dabrafenib 17Radiotherapy 16Temozolomide 15Cisplatin 15Magnetic Resonance Spectroscopy 14Gemcitabine 14Filgrastim 14atezolizumab 13Carboplatin 13CTLA-4 Antigen 13spartalizumab 12romidepsin 12Specimen Handling 12Paclitaxel 12Bortezomib 11poly ICLC 10cobimetinib 10Peripheral Blood Stem Cell Transplantation 10Oxaliplatin 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Surgical Procedures, Operative × Dermatologic × Clear all
NCT01760499 2017-04-19

Detection of Immune Cell Infiltration Into Melanomas Treated by PV-10, a Feasibility Study

H. Lee Moffitt Cancer Center and Research Institute

Phase 1 Completed
15 enrolled
Dermatologic

Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡